| 
Business Insights have joined together with IMS Health to produce a unique set of new management reports which bring together the strength of exclusive IMS Health data sources and Business Insights’ expert analysis of pharmaceutical and biotech markets.
The therapy areas covered within these exclusive reports include;
- The Diabetes Market Outlook
- The Antivirals Market Outlook
- The Asthma and COPD Market Outlook
- The Vaccines Market Outlook
Click here for further details and for the list of publications.
IMS Health
IMS is one of the one leading global sources for pharmaceutical market intelligence, providing critical information, analysis and services that drive decisions and shape strategies. Their unique mix of experience and expertise makes us them the right choice for help in optimizing portfolio, ensuring successful launches, managing brands and improving the effectiveness of sales teams. IMS Health maintain 50 years of industry experience providing unmatched data resources to over 100 countries worldwide.
About Business Insights
Business Insights publish a wide range of healthcare management reports in the pharmaceutical and biotech industries. On average over 30 new healthcare titles are published each year focusing on both global and emerging market analysis. Each report is written by independent experts in the field and is a single source of market analysis providing insight into product and market sales forecasts, competitor analysis, portfolio analysis and winning strategies for the future.
IMS Health gold standard data with trusted expert analysis from
Business Insights provides you with a unique formulae for success…
Our exclusive pharmaceutical management reports provide analysis of changing market dynamics and strategic future outlook of key pharmaceutical therapy areas, using gold standard IMS Health sales data and Business Insights’ expert detailed analysis.
Exclusive reports – no other company provides this unique product range
IMS Health and Business Insights expertise combined differentiates this offering from any other product on the market and the new portfolio of reports will provide pharmaceutical companies with:
- US and European regional market analysis
- Forecasts of market development
- Competitor developments and analysis of leading players.
- Winning market strategies for the future
A “must-have” source of pharmaceutical intelligence not only for those companies that don’t have access to IMS data but also to those companies that do – because it’s the powerful analysis within these reports that will put you ahead of your competitors.
|